PubRank

Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 22971966)

Published in Neurobiol Dis on August 30, 2012

Authors

Annamaria Lanzillotta1, Giuseppe Pignataro2, Caterina Branca1, Ornella Cuomo2, Ilenia Sarnico1, Marina Benarese1, Lucio Annunziato3, PierFranco Spano4, Marina Pizzi5

Author Affiliations

1: Division of Pharmacology and Experimental Therapeutics, Department of Biomedical Sciences & Biotechnologies and National Institute of Neuroscience, School of Medicine, University of Brescia, Italy.
2: Division of Pharmacology, Department of Neuroscience and National Institute of Neuroscience, School of Medicine, Federico II University of Naples, Italy.
3: Division of Pharmacology, Department of Neuroscience and National Institute of Neuroscience, School of Medicine, Federico II University of Naples, Italy; IRCCS SDN, Naples, Italy.
4: Division of Pharmacology and Experimental Therapeutics, Department of Biomedical Sciences & Biotechnologies and National Institute of Neuroscience, School of Medicine, University of Brescia, Italy; IRCCS, S. Camillo Hospital, Venice, Italy.
5: Division of Pharmacology and Experimental Therapeutics, Department of Biomedical Sciences & Biotechnologies and National Institute of Neuroscience, School of Medicine, University of Brescia, Italy; IRCCS, S. Camillo Hospital, Venice, Italy. Electronic address: pizzi@med.unibs.it.

Associated clinical trials:

Predictors of Better Outcomes After Severe Acquired Brain Injuries (FP-GCA) | NCT04495192

Articles citing this ↘

A transient ischemic environment induces reversible compaction of chromatin. Genome Biol (2015) 0.94

Epigenetic mechanisms in cerebral ischemia. J Cereb Blood Flow Metab (2013) 0.93

Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models. ACS Chem Neurosci (2013) 0.92

NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases. Front Neurol (2015) 0.91

Inhibition of histone deacetylases 1 and 3 protects injured retinal ganglion cells. Invest Ophthalmol Vis Sci (2013) 0.89

Resveratrol neuroprotection in stroke and traumatic CNS injury. Neurochem Int (2015) 0.87

Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice. Mol Neurobiol (2014) 0.85

Role of nuclear factor kappa B in central nervous system regeneration. Neural Regen Res (2014) 0.79

Histone Deacetylases Exert Class-Specific Roles in Conditioning the Brain and Heart Against Acute Ischemic Injury. Front Neurol (2015) 0.78

Histone modifications: Targeting head and neck cancer stem cells. World J Stem Cells (2014) 0.78

Ischemic tolerance modulates TRAIL expression and its receptors and generates a neuroprotected phenotype. Cell Death Dis (2014) 0.76

HDAC1-3 inhibitor MS-275 enhances IL10 expression in RAW264.7 macrophages and reduces cigarette smoke-induced airway inflammation in mice. Sci Rep (2017) 0.75

The emerging field of epigenetics in neurodegeneration and neuroprotection. Nat Rev Neurosci (2017) 0.75

Long-term window of ischemic tolerance: An evolutionarily conserved form of metabolic plasticity regulated by epigenetic modifications? J Neurol Neuromedicine (2016) 0.75

Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation. Int J Mol Sci (2017) 0.75

Fermented Chinese formula Shuan-Tong-Ling attenuates ischemic stroke by inhibiting inflammation and apoptosis. Neural Regen Res (2017) 0.75

Resveratrol counteracts lipopolysaccharide-induced depressive-like behaviors via enhanced hippocampal neurogenesis. Oncotarget (2016) 0.75